Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BONESUPPORT HOLDING AB ( (SE:BONEX) ) has shared an announcement.
Bonesupport Holding AB reported strong financial performance for 2025, with net sales rising to SEK 1,175 million and sales growth of 40% at constant exchange rates. The company maintained a high gross margin of 93%, while the U.S. segment grew 46% and the EUROW segment 15%, underscoring its expanding international footprint.
Adjusted operating profit increased to SEK 262 million and earnings per share before dilution reached SEK 2.16, reflecting improved profitability and operational efficiency. These results highlight Bonesupport’s strengthened position in the orthobiologics market and suggest continued momentum in its core regions, supporting confidence among investors and other stakeholders.
More about BONESUPPORT HOLDING AB
Bonesupport Holding AB is a medical technology company focused on orthobiologics, with its CERAMENT-branded products used in bone regeneration and repair. The company targets markets in the U.S. and Europe, where its synthetic bone graft substitutes support surgeons in treating bone defects and related conditions.
Average Trading Volume: 328,957
Technical Sentiment Signal: Buy
Current Market Cap: SEK17.03B
Learn more about BONEX stock on TipRanks’ Stock Analysis page.